Drawing for ZYMENEX

USPTO serial 79178656

ZYMENEX

Reviewed by CopyMark Law Group

Reg. 5088854Status 404
Filing date
Status date
Registration date
Nov 29, 2016
Examiner
DEFORD, JEFFREY S
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZYMENEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Eric T. Fingerhut

Eric T. Fingerhut Dykema Gossett PLLC1301 K Street, N.W.Suite 1100 WestWashington, DC 20005

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of porphyria illness, lysosomal enzyme deficiency diseases, and non-bacterial diseases, namely, cancer, respiratory diseases, cardiovascular diseases, neonatal respiratory distress syndrome, central nervous system disease and other diseases related thereto; enzymes, enzyme-inhibitors, enzyme co-factors and enzyme preparations, namely, enzyme replacement therapy preparations, enzyme replacement therapy products, namely infusions, liquids, tablets and powders for human use in the treatment of genetic disorders, all for medical purposes for the treatment porphyria illness, lysosomal enzyme deficiency diseases; diagnostic preparations for medical purposes used in the field of human illnesses or deficiencies, namely, porphyria illness, lysosomal enzyme deficiency diseases, and non-bacterial diseasesSECTION 71 - CANCELLED—
010Surgical and medical apparatus and instruments, namely, syringes and needles for medical purposes, inhalers sold empty and blood testing apparatus for use in the treatment of porphyria illness, lysosomal enzyme deficiency diseases, and non-bacterial diseasesSECTION 71 - CANCELLED—
016Publications, namely, books, magazines, periodicals and manuals in the fields of medicine and health; printed instructional and teaching matter in the fields of medicine and health; printed instructional material and printed treatment guides in the field of medicine and health issues; manuals concerning the installation and maintenance of computer softwareSECTION 71 - CANCELLED—
041Providing education, training courses and instruction in the fields of medicine and information technology (IT)SECTION 71 - CANCELLED—
042Scientific, industrial, biotechnological and biomedical research in the field of porphyria illness, lysosomal enzyme deficiency diseases, and non-bacterial diseases, namely, cancer, respiratory diseases, cardiovascular diseases, neonatal respiratory distress syndrome, enzyme replacement therapy preparations, enzyme replacement therapy products for human use in the treatment of genetic disorders, central nervous system disease and research concerning the medical treatment thereof; computer services, namely, providing a database featuring data in the field of medical research; designing, implementing and maintaining websites for others; computer network design and installation of computer softwareSECTION 71 - CANCELLED—
044Providing medical information via the Internet; providing medical advice regarding personal management of medical conditions; providing medical advice to health professionals regarding medical conditions; providing medical information and medical counsellingSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 12, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 5, 2026DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Feb 5, 2026DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 17, 2024INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 27, 2024INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 27, 2024INPCINVALIDATION PROCESSED—
Feb 16, 2024INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 16, 2023C71TCANCELLED SECTION 71—
Nov 29, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 8, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 21, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 1, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 14, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 14, 2017FIMPFINAL DISPOSITION PROCESSED—
Feb 28, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 9, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 29, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 21, 2016OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 13, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 13, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 24, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 24, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 24, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 10, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 8, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 8, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 8, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 4, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 4, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 4, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 15, 2016DOCKASSIGNED TO EXAMINER—
Jul 15, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 15, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 11, 2016ALIEASSIGNED TO LIE—
Jul 5, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2016RFNTREFUSAL PROCESSED BY IB—
Jan 7, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 7, 2016RFRRREFUSAL PROCESSED BY MPU—
Dec 30, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 29, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 22, 2015DOCKASSIGNED TO EXAMINER—
Dec 22, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 18, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 17, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance